Committee for Advanced Therapies (CAT) meeting with interested parties
Date:
11/12/2014
Location:
European Medicines Agency, London, UK
CAT engages in active dialogue with its interested parties on a regular basis. During its December 2014 annual meeting CAT and its interested parties discussed the following scientific topics: the revision of the CAT reflection paper on classification with a special emphasis on CAT's current considerations on 'substantial manipulation' and 'non-homologous use'; the application of the concept of risk-based approach during the development and marketing authorisation of advance-therapy-medical products (ATMPs); the CAT work plan for 2015-2016 and other procedures and support to ATMP developers. Other issues and questions from the participating interested parties were also addressed. Registration by invitation only.
-
List item
Agenda - Committee for Advanced Therapies (CAT) meeting with interested parties (PDF/83.97 KB)
First published: 18/05/2015
Last updated: 18/05/2015
EMA/CAT/750592/2014 -
List item
Report of the Committee for Advanced Therapies (CAT) meeting with interested parties (PDF/103.48 KB)
First published: 18/05/2015
Last updated: 18/05/2015
EMA/CAT/23438/2015 -
List item
Presentation - ATMPs classification (Belaà¯d Sekkali) (PDF/1.09 MB)
First published: 12/05/2015
Last updated: 12/05/2015 -
List item
Presentation - CAT’s views on classification of ATMPs: homologous use (Nicolas Ferry) (PDF/1.18 MB)
First published: 12/05/2015
Last updated: 12/05/2015 -
List item
Presentation - The risk-based approach for ATMP (Egbert Flory) (PDF/247.98 KB)
First published: 12/05/2015
Last updated: 12/05/2015 -
List item
Presentation - CAT workplan 2015-2016 (Patrick Celis) (PDF/362.15 KB)
First published: 12/05/2015
Last updated: 12/05/2015